1986
DOI: 10.1177/019459988609400309
|View full text |Cite
|
Sign up to set email alerts
|

The Beneficial Effect of Triamcinolone Acetonide on Nerve Repair with Autogenous Grafts

Abstract: Bilateral nerve cable graft repairs were made in the sciatic nerves of Wistar rats. One group of repairs was treated locally with triamcinolone acetonide (0.5 mg), one group was exposed to the systemic effects of the drug, and one group was left untreated. Nerve regeneration was measured by nerve-stimulated muscle twitch strength, as well as several electrophysiologic parameters of the compound action potential conducted through the graft. Results suggest that nerve regeneration through an autogenous graft is … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
3

Year Published

1993
1993
2013
2013

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 13 publications
(3 reference statements)
0
7
0
3
Order By: Relevance
“…12 There are both experimental and clinical data supporting the notion that the steroid administration may prevent or reduce neural edema. [13][14][15] Patients with idiopathic facial palsy have shown improved facial nerve function after an empirical course of corticosteroids. 16,17 Several randomized clinical trials in many different major and minor surgical procedures have been conducted to examine the effects of a perioperative single-dose glucocorticoid administration on surgical outcome.…”
Section: Otal Thyroidectomy Ormentioning
confidence: 99%
“…12 There are both experimental and clinical data supporting the notion that the steroid administration may prevent or reduce neural edema. [13][14][15] Patients with idiopathic facial palsy have shown improved facial nerve function after an empirical course of corticosteroids. 16,17 Several randomized clinical trials in many different major and minor surgical procedures have been conducted to examine the effects of a perioperative single-dose glucocorticoid administration on surgical outcome.…”
Section: Otal Thyroidectomy Ormentioning
confidence: 99%
“…Várias são as substâncias potencializadoras da regeneração neural e, muitas delas, já usadas em testes clínicos (Levi-Montalcini et al, 1953;Stelmack et al, 1977;Strand et al, 1980;Levi-Montalcini, 1982;Sparrow et al 1982;Hurst et al, 1984;Leeden, 1984;Danielsen et al, 1986;Edwards et al, 1986;Lipton et al, 1986;Badalamente et al, 1987;Bansberg et al, 1987;Mengs et al, 1987;Kaupilla et al, 1988;Zinder, 1988;Badalamente et al, 1989;Chen et al, 1989;Cuello et al, 1989;Kujawa et al, 1989;Klein et al, 1989;Lipton, 1989;Snider et al, 1989;Santos et al, 1991;Lainetti et al, 1993;Costa et al, 1997;Costa et al, 2006).…”
Section: Discussionunclassified
“…Dentre os fármacos mais conhecidos podemos citar: poliaminas e aminoguanidinas (Kaupilla et al, 1988;Gilad et al, 1996), ativadores da adenilciclase (Klein et al, 1989;Urbina et al, 1996;Walikonis et al, 1998), fator de crescimento neural (Levi-Montalcini et al, 1953;Levi-Montalcini,1982;Lipton, 1989;Snider et al, 1989;Chen et al, 1989;Santos et al, 1991;Jubran et al, 2003), triancinolonas (Lipton et al, 1986;Bansberg et al, 1987) , alfa-MSH (Edwards et al, 1986), ACTH (Strand et al, 1980), leupeptina (Hurst et al, 1984;Badalamente et al, 1987;Badalamente et al, 1989;), apoliproteínas (Badalamente et al, 1987), T3 (Stelmack et al, 1977), T4 (Danielsen et al, 1986), testosterona (Kujawa et al, 1989), gangliosídeos (Sparrow et al. 1982;Leeden, 1984;Mengs et al, 1987;Cuello et al, 1989;Laineti et al, 1993) e imunossupressores (Gold, 1997;Costa e al., 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Várias são as substâncias potencializadoras da regeneração neural e, muitas delas, já usadas em testes clínicos (Levi-Montalcini et al, 1953;Stelmack et al, 1977;Strand et al, 1980;Levi-Montalcini, 1982;Sparrow et al 1982;Hurst et al, 1984;Leeden, 1984;Danielsen et al, 1986;Edwards et al, 1986;Lipton et al, 1986;Badalamente et al, 1987;Bansberg et al, 1987;Mengs et al, 1987;Kaupilla et al, 1988;Zinder, 1988;Badalamente et al, 1989;Chen et al, 1989;Cuello et al, 1989;Kujawa et al, 1989;Klein et al, 1989;Lipton, 1989;Snider et al, 1989;Santos et al, 1991;Lainetti et al, 1993;Costa et al, 1997;Costa et al, 2006).…”
Section: Os Animais Dosunclassified
“…Dentre os fármacos mais conhecidos podemos citar: poliaminas e aminoguanidinas (Kaupilla et al, 1988;Gilad et al, 1996), ativadores da adenil-ciclase (Klein et al, 1989;Urbina et al, 1996;Walikonis et al, 1998), fator de crescimento neural (Levi-Montalcini et al, 1953;Levi-Montalcini,1982;Lipton, 1989;Snider et al, 1989;Chen et al, 1989;Santos et al, 1991;Jubran et al, 2003), triancinolonas (Lipton et al, 1986;Bansberg et al, 1987) , alfa-MSH (Edwards et al, 1986), ACTH (Strand et al, 1980), leupeptina (Hurst et al, 1984;Badalamente et al, 1987;Badalamente et al, 1989;), apoliproteínas (Badalamente et al, 1987), T3 (Stelmack et al, 1977), T4 (Danielsen et al, 1986), testosterona (Kujawa et al, 1989, gangliosídeos (Sparrow et al. 1982;Leeden, 1984;Mengs et al, 1987;Cuello et al, 1989;Laineti et al, 1993) e imunossupressores (Gold, 1997;Costa e al., 2006 (Ferreira et al, 1974;Ehrart et al, 1975;Ferreira et al, 1975;Zumiotti et al, 1988;Mattar et al, 1990;Costa, 1998;Costa, 2001 (Ferreira et al, 1985), de paralisias dos membros superiores e inferiores (Ferreira et al, 1974;…”
unclassified